REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

The Lancet

Volumn 332, Issue 8625, 1988, Pages 1394-1399

  Hale, G ^a   Clark, M R ^a   Marcus, R ^a   Winter, G ^b   Dyer, M J S ^a   Phillips, J M ^a   Riechmann, L ^b   Waldmann, H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

AGED; CANCER IMMUNOTHERAPY; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; CASE REPORT; FEMALE; HALF-LIFE; HUMAN; LYMPHOMA, NON-HODGKIN; MALE; REMISSION INDUCTION; SPLENOMEGALY; SUPPORT, NON-U.S. GOV'T;

EID: 0024204319     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)90588-0     Document Type: Article

References (17)

1. Eighty years of immunotherapy: a review of immunological methods used for treatment of human cancer
2. Removal of T cell from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement
3. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation
4. Removal of T cells from bone marrow for transplantation: comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes
5. Isolation of low-frequency class-switch variants from rat hybrid myelomas
6. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes using a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)
7. T-cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation
8. Reshaping human antibodies for therapy
9. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
10. Human monoclonal IgG antibodies differ in complement activation function at the level of C4 as well as C1q
11. Effects of monoclonal anti-lymphocyte antibodies in vivo in monkeys and human
12. Metabolic properties of IgG subclasses in man
13. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma
14. Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies
15. Surface immunoglobulin of B-lymphocyte tumours as a therapeutic target